期刊文献+

分析抗VEGF对新生血管性青光眼治疗的影响

下载PDF
导出
摘要 目的:分析抗VEGF对新生血管性青光眼治疗的影响。方法:选取68例新生血管性青光眼患者,将他们平均分为观察组(34例)和对照组(34例)。观察组接受抗VEGF治疗,对照组接受常规治疗,比较两组患者治疗前后的视力和眼压。结果:治疗结束后两组患者的眼压均有所下降,观察组患者的眼压达至14.2,低于对照组的16.8,术后半年内分三个时间段观察组患者的眼压均低于对照组,并且观察组患者的视力明显高于对照组。结论:抗VEGF对新生血管性青光眼具有良好的治疗效果,值得临床推广。
作者 殷先第
出处 《中外女性健康研究》 2016年第5期44-44,42,共2页 Women's Health Research
  • 相关文献

参考文献3

二级参考文献75

  • 1Rosenfeld PJ, Brown DM, Heier JS, et al. Ranihizumah forneovascular age-related macular degeneration. N Engl J Med,2006,355:1419-1431.
  • 2Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versusverteporfin photodynamic therapy for neovascular age-relatedmacular degeneration : two-year results of the ANCHOR study.Ophthalmology, 2009, 116:57-65.
  • 3Heier JS, Boyer D, Nguyen QD, et al. The 1 -year results ofCLEAR-IT 2,a phase 2 study of vascular endothelial growth factortrap-eye dosed as-needed after 12-week fixed dosing.Ophthalmology, 2011,118:1098-1106.
  • 4Gragoudas ES, Adamis AP,Cunningham ET, et al. Pegaptanibfor neovascular age-related macular degeneration. N Engl J Med,2004,351:1805-1816.
  • 5Li XX, Hu YH, Sun XD, et al. Bevacizumab for neovascular age-related macular degeneration in China. Ophthalmology, 2012 , Inpress.
  • 6Martin DF, Maguire MG, Ying GS, et al. Ranibizumab andBevacizumab for neovascular age-related macular degeneration. NEngl J Med, 2011,364 : 1897-1908.
  • 7Zhang M,Zhang J, Yan M, et al. A phase 1 study of KH902 , avascular endothelial growth factor receptor decoy, for exudativeage-related macular degeneration. Ophthalmology, 2011,118:672-678.
  • 8Kaiser PK, Symons RC,Shah SM, et al. Sirna-027 StudyInvestigators RNAi-based treatment for neovascular age-relatedmacular degeneration by Sirna-027. Am J Ophthalmol, 2010,150:33-39.
  • 9Larsen M, Schmidt-Erfurth U, Lanzetta P, et al. Verteporfin plusRanibizumab for choroidal neovascularization in age-relatedmacular degeneration : twelve-month MONT BLANC study results.Ophthalmology, 2012 , 119:992-1000.
  • 10Koh A, Lee WK, Chen LJ, et al. Everest study : efficacy andsafety of verteporfin photodynamic therapy in combination withRanibizumab or alone versus Ranibizumab monotherapy in patientswith symptomatic macular polypoidal choroidal vasculopathy.Retina, 2012,In press.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部